Pancreatobiliary cases

Disclaimer:

NBI™ and TXI™ technologies are not intended to replace histopathological sampling as a means of diagnosis​

​

NBI™ and TXI™ Technologies are 510(k) cleared in the United State. This case study is being furnished to provide example of NBI™, RDI™ and TXI™ technology use. The TJF-Q290V used in this case is not available in the US market at this time, nor is there an established time for it’s release. The safety and effectiveness of this product and/or the use of these products has not yet been established in the United States market.​

​

The positions and statements made herein by Dr. Moon are based on Dr. Moon’s experiences, thoughts and opinions. As with any product, results may vary, and the techniques, instruments, and settings can vary from facility to facility. The content hereof should not be considered as a substitute for carefully reading all applicable labeling, including the Instructions for Use. Please thoroughly review the relevant user manual(s) for instructions, risks, warnings, and cautions. Techniques, instruments, and setting can vary from facility to facility. It is the clinician’s decision and responsibility in each clinical situation to decide which products, modes, medications, applications, and settings to use.​

​

The EVIS X1™ endoscopy system is not designed for cardiac applications. Other combinations of equipment may cause ventricular fibrillation or seriously affect the cardiac function of the patient. Improper use of endoscopes may result in patient injury, infection, bleeding, and/or perforation. Complete indications, contraindications, warnings, and cautions are available in the Instructions for Use (IFU)

1) Data on file with Olympus (DC00489968)

* Specifications, design and accessories are subject to change without any notice or obligation on the part of the manufacturer